Peyronie's Disease
Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial.
October 9, 2023
What do patients with Peyronie's disease expect from therapy? A prospective multi-center study.
October 2, 2023
Updated recommendations on the therapeutic role of extracorporeal shock wave therapy for peyronie's disease: systematic review and meta-analysis.
September 18, 2023
European Society of Sexual Medicine consensus statement on the use of animal models for studying Peyronie's disease.
September 11, 2023
Insurance approval rates for collagenase clostridium histolyticum prior to discontinuation: a Canada-wide analysis.
September 4, 2023
In vitro efficacy of intralesional Collagenase Clostridium Histolyticum for the treatment of calcified Peyronie's disease plaques.
August 7, 2023
Non-surgical therapies for Peyronie's disease.
July 31, 2023
Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie's Disease.
July 10, 2023
Medical Treatment for Peyronie's Disease: Systematic Review and Network Bayesian Meta-Analysis.
July 3, 2023